Eli Lilly, Qualcomm, Rumble: Market Minute

business people have a meeting about company statistics

Yahoo Finance host Akiko Fujita highlights three of the top trending stocks and stories as part of today's Market Minute.

Pharmaceutical giant Eli Lilly's ( LLY ) GLP-1 weight-loss drug Zepbound received approval by the US Food and Drug Administration (FDA) to treat sleep apnea.

Qualcomm ( QCOM ) was found not to be in violation of an Arm ( ARM ) licensing agreement after the former's acquisition of Nuvia in 2021.

Rumble ( RUM ) shares skyrocket by over 80% Monday morning following a $775 million investment from crypto firm Tether ( USDT-USD ).

To watch more expert insights and analysis on the latest market action, check out more Wealth here .

This post was written by Luke Carberry Mogan .

Related Videos

OK